ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Macro Group Pharmaceuticals - Macro Capital (MCRO.EGX)
Macro Group Pharmaceuticals - Macro Capital stock price today, ATLAS forecast and fair value
Egyptian Exchange · Egypt
EGP 1.24▲ +7.83%
Prices as of Oct 27, 2026 · EGP
Chance of rising in 1 month
48%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Macro Group Pharmaceuticals - Macro Capital in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Macro Group Pharmaceuticals - Macro Capital
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Macro Group Pharmaceuticals - Macro Capital a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between EGP 1.11 and EGP 1.36; in 9 out of 10, between EGP 0.929 and EGP 1.63. Estimated annual volatility is 61%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- EGP 4.11
- 52-week low
- EGP 0.710
- Operating margin
- 0.0%
- Net margin
- 0.0%
What this means
ATLAS does not publish a fair value for MCRO.EGX right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks MCRO.EGX has traded between EGP 0.710 and EGP 4.11. Today it is 69.8% below that high and 75% above its low.
Want to see everything about Macro Group Pharmaceuticals - Macro Capital?
Get started →Plans from €3.99 a month.
Frequently asked questions
What is the chance MCRO.EGX goes up next month?
48%: close to a coin flip. In half of the simulated outcomes, MCRO.EGX ends the month between EGP 1.11 and EGP 1.36.
How volatile is MCRO.EGX?
ATLAS estimates annual volatility at 61%. In a typical month, half of the outcomes end between EGP 1.11 and EGP 1.36.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer